57th ASH Annual Meeting and Exposition (December 5-8, 2015): 902. Health Services and Outcomes Research – Malignant Diseases: Outcomes in Acute Myeloid Leukemia

Health Services and Outcomes Research – Malignant Diseases Oral and Poster Abstracts
Oral

Chapin Theater (W320), Level 3 (Orange County Convention Center)

Moderators:

Selina Luger, MD, University of Pennsylvania and Jessica Pollard, MD, Tufts University

Disclosures:

No relevant conflicts of interest to declare.

7:00 AM

Impact of the Type of Treatment Facility on the Outcome of Acute Myeloid Leukemia in the Adolescents and Young Adults: A National Cancer Data Base (NCDB) Study from 2003-2011

Ronald S GO, MD^1,2^*, Adam C Bartley, MS³^*, Aref Al-Kali, MD¹, Nilay D Shah, PhD⁴^* and Elizabeth B Habermann, PhD, MPH⁴^*

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester
³Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
⁴Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN

7:15 AM

530

Racial Disparities in Pediatric Acute Myeloid Leukemia during Induction

Lena E. Winestone, MD^1,2^*, Kelly Diringer Getz, PhD^1,2^*, Tamara P. Miller, MD¹, Jennifer J. Wilkes, MD^1,2, Leah Sack¹^*, Yimei Li, PhD³^*, Yuan-Shung Huang⁴^*, Alix E. Seif, MD, MPH¹, Rochelle Bagatell, MD^1,5^*, Brian T. Fisher, DO, MSCE⁶^*, Andrew Epstein, PhD, MPP⁷^* and Richard Aplenc, MD, PhD^2,8,9

¹Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA
²Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, PA
³Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA
⁴Healthcare Analytics Unit, Department of General Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA
⁵Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA
⁶Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA
⁷Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁸Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
⁹Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

7:30 AM

531

Risk Factors, Mortality, and Costs of Adults with Acute Myeloid Leukemia (AML) Admitted to the Intensive Care Unit (ICU): A Longitudinal Cohort Study

Anna B. Halpern, MD¹, Eva Culakova, PhD, MS², Roland B. Walter, MD, PhD, MS^3,4,5 and Gary H. Lyman, MD, MPH^3,6,7

¹Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
²Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutchinson Cancer Research Center, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Division of Hematology/Department of Medicine, University of Washington, Seattle, WA
⁵Department of Epidemiology, University of Washington, Seattle, WA
⁶Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁷Division of Medical Oncology/Department of Medicine, University of Washington, Seattle, WA

7:45 AM

532

Impact of Comorbidities at Diagnosis of Acute Myeloid Leukemia on One-Year Mortality

Mohamed L Sorror, MD, MSc¹, Barry E. Storer, PhD²^*, Mahmoud Elsawy, MD, MSc³^*, Amir T Fathi, MD⁴, Andrew Brunner, MD⁵, Aaron T. Gerds, MD, MS⁶, Mikkael A. Sekeres, MD, MS⁶, Sudipto Mukherjee, MD, PhD⁶, Bruno C. Medeiros, MD⁷, Paul Shami, MD⁸, Esteban Peña, MD⁸^*, Shylo Wardyn, MS³^*, Jennifer Whitten, MPH³^*, Hannah Frenkel, BS³^*, Jeannine McCune, PharmD¹^*, Stephanie J. Lee, MD, MPH² and Elihu H. Estey, MD¹

¹Fred Hutchinson Cancer Research Center / University of Washington, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Massachusetts General Hospital/Harvard Medical School, Boston, MA
⁵Massachusetts General Hospital, Harvard Medical School, Boston, MA
⁶Leukemia Program, Cleveland Clinic, Cleveland, OH
⁷Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
⁸Huntsman Cancer Institute, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT

8:00 AM

533

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Smith Giri, MBBS¹, Valerie Shostrom, MS²^*, Krishna Gundabolu, MD³, KM Monirul Islam, MD/PhD⁴^*, Ranjan Pathak, MD⁵, Lori J. Maness, MD³ and Vijaya R. Bhatt, MD³

¹Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN
²University of Nebraska Medical Center, Omaha, NE
³Hematology-Oncology, University of Nebraska Medical Center/Nebraska Medicine, Omaha, NE
⁴University of Nebraska Medical Center, Omaha
⁵Reading Health System, West Reading, PA

8:15 AM

534

Sharing Post-AML Consolidation Supportive Therapy with Local Centers Reduces Patient Travel Burden without Compromising Safety and Efficacy of Care

Samantha A. Hershenfeld, BMSc¹^*, Kimberly Maki, BSc.N, RN¹^*, Lana Rothfels, Hon B.A. & Sc.¹^*, Cindy Susan Murray, BSc.N, MN, NP-Adult¹^*, Aaron D. Schimmer, MD, PhD² and Mary Doherty, Hon BSc.N, MN, NP-PHC¹^*

¹Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada
²Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

See more of: Health Services and Outcomes Research – Malignant Diseases
See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

902.O1.6 902. Health Services and Outcomes Research – Malignant Diseases: Outcomes in Acute Myeloid Leukemia